These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 34144696)
1. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review. Dakurah OB; Tamandjou CRT; Zunza M; Preiser W; Maponga TG BMC Cancer; 2021 Jun; 21(1):715. PubMed ID: 34144696 [TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and infections with multiple hepatitis viruses. Brunetto MR; Oliveri F; Colombatto P; Bonino F Princess Takamatsu Symp; 1995; 25():61-6. PubMed ID: 8875610 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis D virus dual infection increased the risk of hepatocellular carcinoma compared with hepatitis B virus mono infection: A meta-analysis. Chang TE; Su CW; Huang YS; Huang YH; Hou MC; Wu JC J Chin Med Assoc; 2022 Jan; 85(1):30-41. PubMed ID: 35006125 [TBL] [Abstract][Full Text] [Related]
4. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China. Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109 [TBL] [Abstract][Full Text] [Related]
5. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis. Luo X; Wang Y; Shen A; Deng H; Ye M BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders. Mbaga DS; Kenmoe S; Kengne-Ndé C; Ebogo-Belobo JT; Mahamat G; Foe-Essomba JR; Amougou-Atsama M; Tchatchouang S; Nyebe I; Feudjio AF; Kame-Ngasse GI; Magoudjou-Pekam JN; Fokou LKM; Meta-Djomsi D; Maïdadi-Foudi M; Touangnou-Chamda SA; Daha-Tchoffo AG; Selly-Ngaloumo AA; Nayang-Mundo RA; Yéngué JF; Taya-Fokou JB; Kenfack-Momo R; Atembeh Noura E; Demeni Emoh CP; Tazokong HR; Bowo-Ngandji A; Sake CS; Atenguena Okobalemba E; Njiki Bikoi J; Njouom R; Riwom Essama SH PLoS One; 2022; 17(1):e0262903. PubMed ID: 35061846 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis B/D-Related Hepatocellular Carcinoma. A Clinical Literature Review. Baskiran A; Atay A; Baskiran DY; Akbulut S J Gastrointest Cancer; 2021 Dec; 52(4):1192-1197. PubMed ID: 34611832 [TBL] [Abstract][Full Text] [Related]
8. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain. Ramos-Rincon JM; Pinargote-Celorio H; de Mendoza C; Ramos-Belinchón C; Barreiro P; Treviño A; Corral O; Soriano V Hepatol Int; 2022 Oct; 16(5):1161-1169. PubMed ID: 35666390 [TBL] [Abstract][Full Text] [Related]
9. Viral hepatitis and hepatocellular carcinoma. Sallie R; Di Bisceglie AM Gastroenterol Clin North Am; 1994 Sep; 23(3):567-79. PubMed ID: 7989095 [TBL] [Abstract][Full Text] [Related]
10. A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa. Amougou MA; Noah DN; Moundipa PF; Pineau P; Njouom R BMC Infect Dis; 2016 Nov; 16(1):647. PubMed ID: 27821080 [TBL] [Abstract][Full Text] [Related]
11. Epidemiology of hepatitis B, C and D in Malawi: systematic review. Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448 [TBL] [Abstract][Full Text] [Related]
12. Clinical features of hepatitis D. Farci P; Niro GA Semin Liver Dis; 2012 Aug; 32(3):228-36. PubMed ID: 22932971 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of a patient with hepatocellular carcinoma associated with triple hepatitis virus (HBV, HDV, HCV) infection. Koda T; Tamura I; Ishikawa K Kansenshogaku Zasshi; 1998 Nov; 72(11):1188-92. PubMed ID: 9884504 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942 [TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection? Abbas Z; Qureshi M; Hamid S; Jafri W Saudi J Gastroenterol; 2012; 18(1):18-22. PubMed ID: 22249087 [TBL] [Abstract][Full Text] [Related]
17. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166 [TBL] [Abstract][Full Text] [Related]
18. An overview of triple infection with hepatitis B, C and D viruses. Riaz M; Idrees M; Kanwal H; Kabir F Virol J; 2011 Jul; 8():368. PubMed ID: 21791115 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus infection in black patients with hepatocellular carcinoma in southern Africa. Kew MC Princess Takamatsu Symp; 1995; 25():33-40. PubMed ID: 8875607 [TBL] [Abstract][Full Text] [Related]
20. Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies. Kamal H; Fornes R; Simin J; Stål P; Duberg AS; Brusselaers N; Aleman S J Viral Hepat; 2021 Oct; 28(10):1431-1442. PubMed ID: 34291520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]